Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Pharmacy chain ‘massively’ worse off with CPCS profit of just £4,913

A small pharmacy chain is reportedly “massively” worse off since the introduction of the CPCS, with net earnings of just £4,913 in over nine months, C+D has learned.

From April 2020 to January 2021, the chain could claim for 1,747 referrals, resulting in a CPCS income of £24,458, according to analysis of the service across its tens of branches across the UK – which an anonymous contractor who oversees the small pharmacy chain shared with C+D.

Despite a reported CPCS income of more than £24,000, the contractor calculated the net profit to be £4,913 once they factored in the cost of pharmacists’ time to complete each referral, the monetary loss from each uncompleted referral and the profit from over-the-counter sales under the service.

CPCS referral taks 20 minutes on average

The contractor told C+D that they calculated that, on average, it takes their pharmacists about 20 minutes to complete a CPCS referral.

However, there have been instances where pharmacists would be stalled with CPCS referrals for 60 minutes, they added. This could happen when pharmacists spend time on calls “trying to get the patient’s information”, they said.

About 30% of the CPCS referrals the chain cannot claim for are due to patients not being contactable, followed by patients deciding to book a GP appointment instead, according to the contractor.

The £14 fee – which contractors can claim for each completed urgent medicines supply or minor illness referral they make under the service – “does not represent a professional payment for our pharmacists’ professional time”, the anonymous contractor added.

“Massively” worse off

The contractor said according to their analysis, the pharmacy chain is “massively” worse off financially since the launch of the CPCS and the phasing out of medicine use reviews (MURs).

As well as the enhanced fee – at £28 – “MURs were much more manageable because we could intervene with the patients, we could select them, and we could have the discussion”, the contractor said.

“With CPCS, we’re relying on random people being sent to us and we can’t do any quality analysis of that. Everybody who gets sent through to us, we have to talk to, whether they are qualifying [for the service] or not,” they added.

A C+D investigation last year revealed that pharmacies that were signed up to the CPCS in its first six months were getting an average of just under £48 a month.

C+D also reported that, as of May 18 last year, more than 300,000 patients with a minor illness or in need of urgent medicines supply were referred to community pharmacy in just over six months since the launch of the CPCS service.

C+D spent five days in March 2021 analysing the first year of the CPCS. Catch up on the coverage in C+D's dedicated hub and share your experience of the service on the C+D Community.

How much did your pharmacy earn from the CPCS?

Related Content


Pharmacy Manager
Newquay, Cornwall
£ Competitive

Apply Now
Latest News & Analysis
See All



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts